Pimavanserin and Aggression and Social Cognition.

Clinical trial NCT05895513 · RECRUITING

Trial details

NCT number: NCT05895513
Sponsor: Ohio State University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Intermittent Explosive Disorder

Start date: 2024-08-01
Primary completion: 2027-01-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.